Ruvarashe Madzime

Ruvarashe is a PhD student in the Pharmacometrics Group since February 2024.

She holds a BTech (Hons) degree in Biotechnology from the Harare Institute of Technology in Zimbabwe, and a MSc degree in Molecular Biology (Bioinformatics) from Stellenbosch University in South Africa. Her PhD work will include determining the efficacy of a shorter regimen of rifapentine and moxifloxacin in treating tuberculosis in children.